Immune Analysis Using Vitreous Optical Coherence Tomography Imaging in Rats with Steroid-Induced Glaucoma Article Swipe
María Jesús Rodrigo
,
Manuel Subías
,
Alberto Montolío
,
Teresa Martínez
,
Alba Aragón-Navas
,
Irene Bravo‐Osuna
,
Luís E. Pablo
,
J. Banzo
,
Rocío Herrero‐Vanrell
,
Elena García‐Martín
,
Amaya Pérez del Palomar
·
YOU?
·
· 2024
· Open Access
·
· DOI: https://doi.org/10.3390/biomedicines12030633
YOU?
·
· 2024
· Open Access
·
· DOI: https://doi.org/10.3390/biomedicines12030633
Glaucoma is a multifactorial pathology involving the immune system. The subclinical immune response plays a homeostatic role in healthy situations, but in pathological situations, it produces imbalances. Optical coherence tomography detects immune cells in the vitreous as hyperreflective opacities and these are subsequently characterised by computational analysis. This study monitors the changes in immunity in the vitreous in two steroid-induced glaucoma (SIG) animal models created with drug delivery systems (microspheres loaded with dexamethasone and dexamethasone/fibronectin), comparing both sexes and healthy controls over six months. SIG eyes tended to present greater intensity and a higher number of vitreous opacities (p < 0.05), with dynamic fluctuations in the percentage of isolated cells (10 µm2), non-activated cells (10–50 µm2), activated cells (50–250 µm2) and cell complexes (>250 µm2). Both SIG models presented an anti-inflammatory profile, with non-activated cells being the largest population in this study. However, smaller opacities (isolated cells) seemed to be the first responder to noxa since they were the most rounded (recruitment), coinciding with peak intraocular pressure increase, and showed the highest mean Intensity (intracellular machinery), even in the contralateral eye, and a major change in orientation (motility). Studying the features of hyperreflective opacities in the vitreous using OCT could be a useful biomarker of glaucoma.
Related Topics
Concepts
Metadata
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.3390/biomedicines12030633
- https://www.mdpi.com/2227-9059/12/3/633/pdf?version=1710317982
- OA Status
- gold
- References
- 72
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4392746058
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4392746058Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.3390/biomedicines12030633Digital Object Identifier
- Title
-
Immune Analysis Using Vitreous Optical Coherence Tomography Imaging in Rats with Steroid-Induced GlaucomaWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2024Year of publication
- Publication date
-
2024-03-13Full publication date if available
- Authors
-
María Jesús Rodrigo, Manuel Subías, Alberto Montolío, Teresa Martínez, Alba Aragón-Navas, Irene Bravo‐Osuna, Luís E. Pablo, J. Banzo, Rocío Herrero‐Vanrell, Elena García‐Martín, Amaya Pérez del PalomarList of authors in order
- Landing page
-
https://doi.org/10.3390/biomedicines12030633Publisher landing page
- PDF URL
-
https://www.mdpi.com/2227-9059/12/3/633/pdf?version=1710317982Direct link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
goldOpen access status per OpenAlex
- OA URL
-
https://www.mdpi.com/2227-9059/12/3/633/pdf?version=1710317982Direct OA link when available
- Concepts
-
Glaucoma, Immune system, Dexamethasone, Intraocular pressure, Population, Medicine, Ophthalmology, Optical coherence tomography, Pathology, Immunology, Internal medicine, Environmental healthTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
0Total citation count in OpenAlex
- References (count)
-
72Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4392746058 |
|---|---|
| doi | https://doi.org/10.3390/biomedicines12030633 |
| ids.doi | https://doi.org/10.3390/biomedicines12030633 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/38540246 |
| ids.openalex | https://openalex.org/W4392746058 |
| fwci | 0.0 |
| type | article |
| title | Immune Analysis Using Vitreous Optical Coherence Tomography Imaging in Rats with Steroid-Induced Glaucoma |
| biblio.issue | 3 |
| biblio.volume | 12 |
| biblio.last_page | 633 |
| biblio.first_page | 633 |
| topics[0].id | https://openalex.org/T10250 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 1.0 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2731 |
| topics[0].subfield.display_name | Ophthalmology |
| topics[0].display_name | Glaucoma and retinal disorders |
| topics[1].id | https://openalex.org/T10170 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.9997000098228455 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2731 |
| topics[1].subfield.display_name | Ophthalmology |
| topics[1].display_name | Retinal Diseases and Treatments |
| topics[2].id | https://openalex.org/T10691 |
| topics[2].field.id | https://openalex.org/fields/13 |
| topics[2].field.display_name | Biochemistry, Genetics and Molecular Biology |
| topics[2].score | 0.996399998664856 |
| topics[2].domain.id | https://openalex.org/domains/1 |
| topics[2].domain.display_name | Life Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/1312 |
| topics[2].subfield.display_name | Molecular Biology |
| topics[2].display_name | Retinal Development and Disorders |
| is_xpac | False |
| apc_list.value | 2200 |
| apc_list.currency | CHF |
| apc_list.value_usd | 2382 |
| apc_paid.value | 2200 |
| apc_paid.currency | CHF |
| apc_paid.value_usd | 2382 |
| concepts[0].id | https://openalex.org/C2778527774 |
| concepts[0].level | 2 |
| concepts[0].score | 0.7606537342071533 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q159701 |
| concepts[0].display_name | Glaucoma |
| concepts[1].id | https://openalex.org/C8891405 |
| concepts[1].level | 2 |
| concepts[1].score | 0.7479531764984131 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q1059 |
| concepts[1].display_name | Immune system |
| concepts[2].id | https://openalex.org/C2780401358 |
| concepts[2].level | 2 |
| concepts[2].score | 0.6906892657279968 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q422252 |
| concepts[2].display_name | Dexamethasone |
| concepts[3].id | https://openalex.org/C2781092963 |
| concepts[3].level | 2 |
| concepts[3].score | 0.6670951247215271 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q650050 |
| concepts[3].display_name | Intraocular pressure |
| concepts[4].id | https://openalex.org/C2908647359 |
| concepts[4].level | 2 |
| concepts[4].score | 0.4904801547527313 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q2625603 |
| concepts[4].display_name | Population |
| concepts[5].id | https://openalex.org/C71924100 |
| concepts[5].level | 0 |
| concepts[5].score | 0.4845987558364868 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[5].display_name | Medicine |
| concepts[6].id | https://openalex.org/C118487528 |
| concepts[6].level | 1 |
| concepts[6].score | 0.4780043661594391 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q161437 |
| concepts[6].display_name | Ophthalmology |
| concepts[7].id | https://openalex.org/C2778818243 |
| concepts[7].level | 2 |
| concepts[7].score | 0.47566670179367065 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q899552 |
| concepts[7].display_name | Optical coherence tomography |
| concepts[8].id | https://openalex.org/C142724271 |
| concepts[8].level | 1 |
| concepts[8].score | 0.41659682989120483 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q7208 |
| concepts[8].display_name | Pathology |
| concepts[9].id | https://openalex.org/C203014093 |
| concepts[9].level | 1 |
| concepts[9].score | 0.29331493377685547 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q101929 |
| concepts[9].display_name | Immunology |
| concepts[10].id | https://openalex.org/C126322002 |
| concepts[10].level | 1 |
| concepts[10].score | 0.2048313319683075 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[10].display_name | Internal medicine |
| concepts[11].id | https://openalex.org/C99454951 |
| concepts[11].level | 1 |
| concepts[11].score | 0.0 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q932068 |
| concepts[11].display_name | Environmental health |
| keywords[0].id | https://openalex.org/keywords/glaucoma |
| keywords[0].score | 0.7606537342071533 |
| keywords[0].display_name | Glaucoma |
| keywords[1].id | https://openalex.org/keywords/immune-system |
| keywords[1].score | 0.7479531764984131 |
| keywords[1].display_name | Immune system |
| keywords[2].id | https://openalex.org/keywords/dexamethasone |
| keywords[2].score | 0.6906892657279968 |
| keywords[2].display_name | Dexamethasone |
| keywords[3].id | https://openalex.org/keywords/intraocular-pressure |
| keywords[3].score | 0.6670951247215271 |
| keywords[3].display_name | Intraocular pressure |
| keywords[4].id | https://openalex.org/keywords/population |
| keywords[4].score | 0.4904801547527313 |
| keywords[4].display_name | Population |
| keywords[5].id | https://openalex.org/keywords/medicine |
| keywords[5].score | 0.4845987558364868 |
| keywords[5].display_name | Medicine |
| keywords[6].id | https://openalex.org/keywords/ophthalmology |
| keywords[6].score | 0.4780043661594391 |
| keywords[6].display_name | Ophthalmology |
| keywords[7].id | https://openalex.org/keywords/optical-coherence-tomography |
| keywords[7].score | 0.47566670179367065 |
| keywords[7].display_name | Optical coherence tomography |
| keywords[8].id | https://openalex.org/keywords/pathology |
| keywords[8].score | 0.41659682989120483 |
| keywords[8].display_name | Pathology |
| keywords[9].id | https://openalex.org/keywords/immunology |
| keywords[9].score | 0.29331493377685547 |
| keywords[9].display_name | Immunology |
| keywords[10].id | https://openalex.org/keywords/internal-medicine |
| keywords[10].score | 0.2048313319683075 |
| keywords[10].display_name | Internal medicine |
| language | en |
| locations[0].id | doi:10.3390/biomedicines12030633 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S2737005842 |
| locations[0].source.issn | 2227-9059 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | True |
| locations[0].source.issn_l | 2227-9059 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | True |
| locations[0].source.display_name | Biomedicines |
| locations[0].source.host_organization | https://openalex.org/P4310310987 |
| locations[0].source.host_organization_name | Multidisciplinary Digital Publishing Institute |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310310987 |
| locations[0].license | cc-by |
| locations[0].pdf_url | https://www.mdpi.com/2227-9059/12/3/633/pdf?version=1710317982 |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | https://openalex.org/licenses/cc-by |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Biomedicines |
| locations[0].landing_page_url | https://doi.org/10.3390/biomedicines12030633 |
| locations[1].id | pmid:38540246 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | Biomedicines |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/38540246 |
| locations[2].id | pmh:oai:pubmedcentral.nih.gov:10967960 |
| locations[2].is_oa | True |
| locations[2].source.id | https://openalex.org/S2764455111 |
| locations[2].source.issn | |
| locations[2].source.type | repository |
| locations[2].source.is_oa | False |
| locations[2].source.issn_l | |
| locations[2].source.is_core | False |
| locations[2].source.is_in_doaj | False |
| locations[2].source.display_name | PubMed Central |
| locations[2].source.host_organization | https://openalex.org/I1299303238 |
| locations[2].source.host_organization_name | National Institutes of Health |
| locations[2].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[2].license | cc-by |
| locations[2].pdf_url | https://pmc.ncbi.nlm.nih.gov/articles/PMC10967960/pdf/biomedicines-12-00633.pdf |
| locations[2].version | submittedVersion |
| locations[2].raw_type | Text |
| locations[2].license_id | https://openalex.org/licenses/cc-by |
| locations[2].is_accepted | False |
| locations[2].is_published | False |
| locations[2].raw_source_name | Biomedicines |
| locations[2].landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/10967960 |
| locations[3].id | pmh:oai:doaj.org/article:1aa404abc0a24b03a76b0bcf5e9d74bc |
| locations[3].is_oa | False |
| locations[3].source.id | https://openalex.org/S4306401280 |
| locations[3].source.issn | |
| locations[3].source.type | repository |
| locations[3].source.is_oa | False |
| locations[3].source.issn_l | |
| locations[3].source.is_core | False |
| locations[3].source.is_in_doaj | False |
| locations[3].source.display_name | DOAJ (DOAJ: Directory of Open Access Journals) |
| locations[3].source.host_organization | |
| locations[3].source.host_organization_name | |
| locations[3].source.host_organization_lineage | |
| locations[3].license | |
| locations[3].pdf_url | |
| locations[3].version | submittedVersion |
| locations[3].raw_type | article |
| locations[3].license_id | |
| locations[3].is_accepted | False |
| locations[3].is_published | False |
| locations[3].raw_source_name | Biomedicines, Vol 12, Iss 3, p 633 (2024) |
| locations[3].landing_page_url | https://doaj.org/article/1aa404abc0a24b03a76b0bcf5e9d74bc |
| locations[4].id | pmh:oai:zaguan.unizar.es:133256 |
| locations[4].is_oa | True |
| locations[4].source.id | https://openalex.org/S4306401812 |
| locations[4].source.issn | |
| locations[4].source.type | repository |
| locations[4].source.is_oa | False |
| locations[4].source.issn_l | |
| locations[4].source.is_core | False |
| locations[4].source.is_in_doaj | False |
| locations[4].source.display_name | Zaguan (University of Zaragoza Repository) |
| locations[4].source.host_organization | https://openalex.org/I255234318 |
| locations[4].source.host_organization_name | Universidad de Zaragoza |
| locations[4].source.host_organization_lineage | https://openalex.org/I255234318 |
| locations[4].license | cc-by |
| locations[4].pdf_url | |
| locations[4].version | submittedVersion |
| locations[4].raw_type | info:eu-repo/semantics/article |
| locations[4].license_id | https://openalex.org/licenses/cc-by |
| locations[4].is_accepted | False |
| locations[4].is_published | False |
| locations[4].raw_source_name | |
| locations[4].landing_page_url | http://zaguan.unizar.es/record/133256 |
| indexed_in | crossref, doaj, pubmed |
| authorships[0].author.id | https://openalex.org/A5069261832 |
| authorships[0].author.orcid | https://orcid.org/0000-0002-4009-3075 |
| authorships[0].author.display_name | María Jesús Rodrigo |
| authorships[0].countries | ES |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I2801357902 |
| authorships[0].affiliations[0].raw_affiliation_string | National Ocular Researcha Network RD21/0002/0050, RICORS Red de Enfermedades Inflamatorias (RD21/0002), Carlos III Health Institute, 28220 Madrid, Spain |
| authorships[0].affiliations[1].institution_ids | https://openalex.org/I255234318, https://openalex.org/I4210136512 |
| authorships[0].affiliations[1].raw_affiliation_string | Miguel Servet Ophthalmology Research Group (GIMSO), Aragon Health Research Institute (IIS Aragon), University of Zaragoza, 50009 Zaragoza, Spain |
| authorships[0].affiliations[2].institution_ids | https://openalex.org/I4210114530 |
| authorships[0].affiliations[2].raw_affiliation_string | Department of Ophthalmology, Miguel Servet University Hospital, 50009 Zaragoza, Spain |
| authorships[0].institutions[0].id | https://openalex.org/I4210114530 |
| authorships[0].institutions[0].ror | https://ror.org/01r13mt55 |
| authorships[0].institutions[0].type | healthcare |
| authorships[0].institutions[0].lineage | https://openalex.org/I4210114530 |
| authorships[0].institutions[0].country_code | ES |
| authorships[0].institutions[0].display_name | Hospital Universitario Miguel Servet |
| authorships[0].institutions[1].id | https://openalex.org/I4210136512 |
| authorships[0].institutions[1].ror | https://ror.org/03njn4610 |
| authorships[0].institutions[1].type | other |
| authorships[0].institutions[1].lineage | https://openalex.org/I4210136512 |
| authorships[0].institutions[1].country_code | ES |
| authorships[0].institutions[1].display_name | Instituto de Investigación Sanitaria Aragón |
| authorships[0].institutions[2].id | https://openalex.org/I2801357902 |
| authorships[0].institutions[2].ror | https://ror.org/00ca2c886 |
| authorships[0].institutions[2].type | nonprofit |
| authorships[0].institutions[2].lineage | https://openalex.org/I2801357902, https://openalex.org/I4387152914 |
| authorships[0].institutions[2].country_code | ES |
| authorships[0].institutions[2].display_name | Instituto de Salud Carlos III |
| authorships[0].institutions[3].id | https://openalex.org/I255234318 |
| authorships[0].institutions[3].ror | https://ror.org/012a91z28 |
| authorships[0].institutions[3].type | education |
| authorships[0].institutions[3].lineage | https://openalex.org/I255234318 |
| authorships[0].institutions[3].country_code | ES |
| authorships[0].institutions[3].display_name | Universidad de Zaragoza |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Maria J. Rodrigo |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | Department of Ophthalmology, Miguel Servet University Hospital, 50009 Zaragoza, Spain, Miguel Servet Ophthalmology Research Group (GIMSO), Aragon Health Research Institute (IIS Aragon), University of Zaragoza, 50009 Zaragoza, Spain, National Ocular Researcha Network RD21/0002/0050, RICORS Red de Enfermedades Inflamatorias (RD21/0002), Carlos III Health Institute, 28220 Madrid, Spain |
| authorships[1].author.id | https://openalex.org/A5019494571 |
| authorships[1].author.orcid | https://orcid.org/0000-0002-2344-016X |
| authorships[1].author.display_name | Manuel Subías |
| authorships[1].countries | ES |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I255234318, https://openalex.org/I4210136512 |
| authorships[1].affiliations[0].raw_affiliation_string | Miguel Servet Ophthalmology Research Group (GIMSO), Aragon Health Research Institute (IIS Aragon), University of Zaragoza, 50009 Zaragoza, Spain |
| authorships[1].affiliations[1].raw_affiliation_string | Biotech Vision, Instituto Oftalmologico Quiron, 50012 Zaragoza, Spain |
| authorships[1].affiliations[2].institution_ids | https://openalex.org/I4210114530 |
| authorships[1].affiliations[2].raw_affiliation_string | Department of Ophthalmology, Miguel Servet University Hospital, 50009 Zaragoza, Spain |
| authorships[1].institutions[0].id | https://openalex.org/I4210114530 |
| authorships[1].institutions[0].ror | https://ror.org/01r13mt55 |
| authorships[1].institutions[0].type | healthcare |
| authorships[1].institutions[0].lineage | https://openalex.org/I4210114530 |
| authorships[1].institutions[0].country_code | ES |
| authorships[1].institutions[0].display_name | Hospital Universitario Miguel Servet |
| authorships[1].institutions[1].id | https://openalex.org/I4210136512 |
| authorships[1].institutions[1].ror | https://ror.org/03njn4610 |
| authorships[1].institutions[1].type | other |
| authorships[1].institutions[1].lineage | https://openalex.org/I4210136512 |
| authorships[1].institutions[1].country_code | ES |
| authorships[1].institutions[1].display_name | Instituto de Investigación Sanitaria Aragón |
| authorships[1].institutions[2].id | https://openalex.org/I255234318 |
| authorships[1].institutions[2].ror | https://ror.org/012a91z28 |
| authorships[1].institutions[2].type | education |
| authorships[1].institutions[2].lineage | https://openalex.org/I255234318 |
| authorships[1].institutions[2].country_code | ES |
| authorships[1].institutions[2].display_name | Universidad de Zaragoza |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Manuel Subías |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Biotech Vision, Instituto Oftalmologico Quiron, 50012 Zaragoza, Spain, Department of Ophthalmology, Miguel Servet University Hospital, 50009 Zaragoza, Spain, Miguel Servet Ophthalmology Research Group (GIMSO), Aragon Health Research Institute (IIS Aragon), University of Zaragoza, 50009 Zaragoza, Spain |
| authorships[2].author.id | https://openalex.org/A5062013995 |
| authorships[2].author.orcid | https://orcid.org/0000-0001-7248-4399 |
| authorships[2].author.display_name | Alberto Montolío |
| authorships[2].countries | ES |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I255234318 |
| authorships[2].affiliations[0].raw_affiliation_string | Department of Mechanical Engineering, University of Zaragoza, 50018 Zaragoza, Spain |
| authorships[2].affiliations[1].institution_ids | https://openalex.org/I255234318 |
| authorships[2].affiliations[1].raw_affiliation_string | Biomaterials Group, Aragon Engineering Research Institute (I3A), University of Zaragoza, 50018 Zaragoza, Spain |
| authorships[2].institutions[0].id | https://openalex.org/I255234318 |
| authorships[2].institutions[0].ror | https://ror.org/012a91z28 |
| authorships[2].institutions[0].type | education |
| authorships[2].institutions[0].lineage | https://openalex.org/I255234318 |
| authorships[2].institutions[0].country_code | ES |
| authorships[2].institutions[0].display_name | Universidad de Zaragoza |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Alberto Montolío |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Biomaterials Group, Aragon Engineering Research Institute (I3A), University of Zaragoza, 50018 Zaragoza, Spain, Department of Mechanical Engineering, University of Zaragoza, 50018 Zaragoza, Spain |
| authorships[3].author.id | https://openalex.org/A5101442928 |
| authorships[3].author.orcid | https://orcid.org/0000-0002-8891-0417 |
| authorships[3].author.display_name | Teresa Martínez |
| authorships[3].countries | ES |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I4210114530 |
| authorships[3].affiliations[0].raw_affiliation_string | Department of Ophthalmology, Miguel Servet University Hospital, 50009 Zaragoza, Spain |
| authorships[3].affiliations[1].institution_ids | https://openalex.org/I255234318, https://openalex.org/I4210136512 |
| authorships[3].affiliations[1].raw_affiliation_string | Miguel Servet Ophthalmology Research Group (GIMSO), Aragon Health Research Institute (IIS Aragon), University of Zaragoza, 50009 Zaragoza, Spain |
| authorships[3].institutions[0].id | https://openalex.org/I4210114530 |
| authorships[3].institutions[0].ror | https://ror.org/01r13mt55 |
| authorships[3].institutions[0].type | healthcare |
| authorships[3].institutions[0].lineage | https://openalex.org/I4210114530 |
| authorships[3].institutions[0].country_code | ES |
| authorships[3].institutions[0].display_name | Hospital Universitario Miguel Servet |
| authorships[3].institutions[1].id | https://openalex.org/I4210136512 |
| authorships[3].institutions[1].ror | https://ror.org/03njn4610 |
| authorships[3].institutions[1].type | other |
| authorships[3].institutions[1].lineage | https://openalex.org/I4210136512 |
| authorships[3].institutions[1].country_code | ES |
| authorships[3].institutions[1].display_name | Instituto de Investigación Sanitaria Aragón |
| authorships[3].institutions[2].id | https://openalex.org/I255234318 |
| authorships[3].institutions[2].ror | https://ror.org/012a91z28 |
| authorships[3].institutions[2].type | education |
| authorships[3].institutions[2].lineage | https://openalex.org/I255234318 |
| authorships[3].institutions[2].country_code | ES |
| authorships[3].institutions[2].display_name | Universidad de Zaragoza |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Teresa Martínez-Rincón |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Department of Ophthalmology, Miguel Servet University Hospital, 50009 Zaragoza, Spain, Miguel Servet Ophthalmology Research Group (GIMSO), Aragon Health Research Institute (IIS Aragon), University of Zaragoza, 50009 Zaragoza, Spain |
| authorships[4].author.id | https://openalex.org/A5017381888 |
| authorships[4].author.orcid | https://orcid.org/0000-0002-7466-8914 |
| authorships[4].author.display_name | Alba Aragón-Navas |
| authorships[4].countries | ES |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I121748325 |
| authorships[4].affiliations[0].raw_affiliation_string | Innovation, Therapy and Pharmaceutical Development in Ophthalmology (InnOftal) Research Group, UCM 920415, Department of Pharmaceutics and Food Technology, Faculty of Pharmacy, Complutense University of Madrid, 28040 Madrid, Spain |
| authorships[4].affiliations[1].institution_ids | https://openalex.org/I121748325 |
| authorships[4].affiliations[1].raw_affiliation_string | University Institute of Industrial Pharmacy (IUFI), School of Pharmacy, Complutense University of Madrid, 28040 Madrid, Spain |
| authorships[4].affiliations[2].institution_ids | https://openalex.org/I4210097846 |
| authorships[4].affiliations[2].raw_affiliation_string | Health Research Institute of the San Carlos Clinical Hospital (IdISSC), 28040 Madrid, Spain |
| authorships[4].institutions[0].id | https://openalex.org/I4210097846 |
| authorships[4].institutions[0].ror | https://ror.org/014v12a39 |
| authorships[4].institutions[0].type | healthcare |
| authorships[4].institutions[0].lineage | https://openalex.org/I4210097846 |
| authorships[4].institutions[0].country_code | ES |
| authorships[4].institutions[0].display_name | Instituto de Investigación Sanitaria del Hospital Clínico San Carlos |
| authorships[4].institutions[1].id | https://openalex.org/I121748325 |
| authorships[4].institutions[1].ror | https://ror.org/02p0gd045 |
| authorships[4].institutions[1].type | education |
| authorships[4].institutions[1].lineage | https://openalex.org/I121748325 |
| authorships[4].institutions[1].country_code | ES |
| authorships[4].institutions[1].display_name | Universidad Complutense de Madrid |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Alba Aragón-Navas |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | Health Research Institute of the San Carlos Clinical Hospital (IdISSC), 28040 Madrid, Spain, Innovation, Therapy and Pharmaceutical Development in Ophthalmology (InnOftal) Research Group, UCM 920415, Department of Pharmaceutics and Food Technology, Faculty of Pharmacy, Complutense University of Madrid, 28040 Madrid, Spain, University Institute of Industrial Pharmacy (IUFI), School of Pharmacy, Complutense University of Madrid, 28040 Madrid, Spain |
| authorships[5].author.id | https://openalex.org/A5067450361 |
| authorships[5].author.orcid | https://orcid.org/0000-0003-3133-7872 |
| authorships[5].author.display_name | Irene Bravo‐Osuna |
| authorships[5].countries | ES |
| authorships[5].affiliations[0].institution_ids | https://openalex.org/I121748325 |
| authorships[5].affiliations[0].raw_affiliation_string | Innovation, Therapy and Pharmaceutical Development in Ophthalmology (InnOftal) Research Group, UCM 920415, Department of Pharmaceutics and Food Technology, Faculty of Pharmacy, Complutense University of Madrid, 28040 Madrid, Spain |
| authorships[5].affiliations[1].institution_ids | https://openalex.org/I121748325 |
| authorships[5].affiliations[1].raw_affiliation_string | University Institute of Industrial Pharmacy (IUFI), School of Pharmacy, Complutense University of Madrid, 28040 Madrid, Spain |
| authorships[5].affiliations[2].institution_ids | https://openalex.org/I4210097846 |
| authorships[5].affiliations[2].raw_affiliation_string | Health Research Institute of the San Carlos Clinical Hospital (IdISSC), 28040 Madrid, Spain |
| authorships[5].institutions[0].id | https://openalex.org/I4210097846 |
| authorships[5].institutions[0].ror | https://ror.org/014v12a39 |
| authorships[5].institutions[0].type | healthcare |
| authorships[5].institutions[0].lineage | https://openalex.org/I4210097846 |
| authorships[5].institutions[0].country_code | ES |
| authorships[5].institutions[0].display_name | Instituto de Investigación Sanitaria del Hospital Clínico San Carlos |
| authorships[5].institutions[1].id | https://openalex.org/I121748325 |
| authorships[5].institutions[1].ror | https://ror.org/02p0gd045 |
| authorships[5].institutions[1].type | education |
| authorships[5].institutions[1].lineage | https://openalex.org/I121748325 |
| authorships[5].institutions[1].country_code | ES |
| authorships[5].institutions[1].display_name | Universidad Complutense de Madrid |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Irene Bravo-Osuna |
| authorships[5].is_corresponding | False |
| authorships[5].raw_affiliation_strings | Health Research Institute of the San Carlos Clinical Hospital (IdISSC), 28040 Madrid, Spain, Innovation, Therapy and Pharmaceutical Development in Ophthalmology (InnOftal) Research Group, UCM 920415, Department of Pharmaceutics and Food Technology, Faculty of Pharmacy, Complutense University of Madrid, 28040 Madrid, Spain, University Institute of Industrial Pharmacy (IUFI), School of Pharmacy, Complutense University of Madrid, 28040 Madrid, Spain |
| authorships[6].author.id | https://openalex.org/A5089248502 |
| authorships[6].author.orcid | https://orcid.org/0000-0003-2389-8282 |
| authorships[6].author.display_name | Luís E. Pablo |
| authorships[6].countries | ES |
| authorships[6].affiliations[0].institution_ids | https://openalex.org/I2801357902 |
| authorships[6].affiliations[0].raw_affiliation_string | National Ocular Researcha Network RD21/0002/0050, RICORS Red de Enfermedades Inflamatorias (RD21/0002), Carlos III Health Institute, 28220 Madrid, Spain |
| authorships[6].affiliations[1].institution_ids | https://openalex.org/I4210114530 |
| authorships[6].affiliations[1].raw_affiliation_string | Department of Ophthalmology, Miguel Servet University Hospital, 50009 Zaragoza, Spain |
| authorships[6].affiliations[2].institution_ids | https://openalex.org/I255234318, https://openalex.org/I4210136512 |
| authorships[6].affiliations[2].raw_affiliation_string | Miguel Servet Ophthalmology Research Group (GIMSO), Aragon Health Research Institute (IIS Aragon), University of Zaragoza, 50009 Zaragoza, Spain |
| authorships[6].affiliations[3].raw_affiliation_string | Biotech Vision, Instituto Oftalmologico Quiron, 50012 Zaragoza, Spain |
| authorships[6].institutions[0].id | https://openalex.org/I4210114530 |
| authorships[6].institutions[0].ror | https://ror.org/01r13mt55 |
| authorships[6].institutions[0].type | healthcare |
| authorships[6].institutions[0].lineage | https://openalex.org/I4210114530 |
| authorships[6].institutions[0].country_code | ES |
| authorships[6].institutions[0].display_name | Hospital Universitario Miguel Servet |
| authorships[6].institutions[1].id | https://openalex.org/I4210136512 |
| authorships[6].institutions[1].ror | https://ror.org/03njn4610 |
| authorships[6].institutions[1].type | other |
| authorships[6].institutions[1].lineage | https://openalex.org/I4210136512 |
| authorships[6].institutions[1].country_code | ES |
| authorships[6].institutions[1].display_name | Instituto de Investigación Sanitaria Aragón |
| authorships[6].institutions[2].id | https://openalex.org/I2801357902 |
| authorships[6].institutions[2].ror | https://ror.org/00ca2c886 |
| authorships[6].institutions[2].type | nonprofit |
| authorships[6].institutions[2].lineage | https://openalex.org/I2801357902, https://openalex.org/I4387152914 |
| authorships[6].institutions[2].country_code | ES |
| authorships[6].institutions[2].display_name | Instituto de Salud Carlos III |
| authorships[6].institutions[3].id | https://openalex.org/I255234318 |
| authorships[6].institutions[3].ror | https://ror.org/012a91z28 |
| authorships[6].institutions[3].type | education |
| authorships[6].institutions[3].lineage | https://openalex.org/I255234318 |
| authorships[6].institutions[3].country_code | ES |
| authorships[6].institutions[3].display_name | Universidad de Zaragoza |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | Luis E. Pablo |
| authorships[6].is_corresponding | False |
| authorships[6].raw_affiliation_strings | Biotech Vision, Instituto Oftalmologico Quiron, 50012 Zaragoza, Spain, Department of Ophthalmology, Miguel Servet University Hospital, 50009 Zaragoza, Spain, Miguel Servet Ophthalmology Research Group (GIMSO), Aragon Health Research Institute (IIS Aragon), University of Zaragoza, 50009 Zaragoza, Spain, National Ocular Researcha Network RD21/0002/0050, RICORS Red de Enfermedades Inflamatorias (RD21/0002), Carlos III Health Institute, 28220 Madrid, Spain |
| authorships[7].author.id | https://openalex.org/A5011290880 |
| authorships[7].author.orcid | https://orcid.org/0000-0002-2967-6747 |
| authorships[7].author.display_name | J. Banzo |
| authorships[7].countries | ES |
| authorships[7].affiliations[0].institution_ids | https://openalex.org/I255234318 |
| authorships[7].affiliations[0].raw_affiliation_string | Biomaterials Group, Aragon Engineering Research Institute (I3A), University of Zaragoza, 50018 Zaragoza, Spain |
| authorships[7].affiliations[1].institution_ids | https://openalex.org/I255234318 |
| authorships[7].affiliations[1].raw_affiliation_string | Department of Mechanical Engineering, University of Zaragoza, 50018 Zaragoza, Spain |
| authorships[7].institutions[0].id | https://openalex.org/I255234318 |
| authorships[7].institutions[0].ror | https://ror.org/012a91z28 |
| authorships[7].institutions[0].type | education |
| authorships[7].institutions[0].lineage | https://openalex.org/I255234318 |
| authorships[7].institutions[0].country_code | ES |
| authorships[7].institutions[0].display_name | Universidad de Zaragoza |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | Jose Cegoñino |
| authorships[7].is_corresponding | False |
| authorships[7].raw_affiliation_strings | Biomaterials Group, Aragon Engineering Research Institute (I3A), University of Zaragoza, 50018 Zaragoza, Spain, Department of Mechanical Engineering, University of Zaragoza, 50018 Zaragoza, Spain |
| authorships[8].author.id | https://openalex.org/A5073742899 |
| authorships[8].author.orcid | https://orcid.org/0000-0001-9764-7975 |
| authorships[8].author.display_name | Rocío Herrero‐Vanrell |
| authorships[8].countries | ES |
| authorships[8].affiliations[0].institution_ids | https://openalex.org/I121748325 |
| authorships[8].affiliations[0].raw_affiliation_string | University Institute of Industrial Pharmacy (IUFI), School of Pharmacy, Complutense University of Madrid, 28040 Madrid, Spain |
| authorships[8].affiliations[1].institution_ids | https://openalex.org/I4210097846 |
| authorships[8].affiliations[1].raw_affiliation_string | Health Research Institute of the San Carlos Clinical Hospital (IdISSC), 28040 Madrid, Spain |
| authorships[8].institutions[0].id | https://openalex.org/I4210097846 |
| authorships[8].institutions[0].ror | https://ror.org/014v12a39 |
| authorships[8].institutions[0].type | healthcare |
| authorships[8].institutions[0].lineage | https://openalex.org/I4210097846 |
| authorships[8].institutions[0].country_code | ES |
| authorships[8].institutions[0].display_name | Instituto de Investigación Sanitaria del Hospital Clínico San Carlos |
| authorships[8].institutions[1].id | https://openalex.org/I121748325 |
| authorships[8].institutions[1].ror | https://ror.org/02p0gd045 |
| authorships[8].institutions[1].type | education |
| authorships[8].institutions[1].lineage | https://openalex.org/I121748325 |
| authorships[8].institutions[1].country_code | ES |
| authorships[8].institutions[1].display_name | Universidad Complutense de Madrid |
| authorships[8].author_position | middle |
| authorships[8].raw_author_name | Rocío Herrero-Vanrell |
| authorships[8].is_corresponding | False |
| authorships[8].raw_affiliation_strings | Health Research Institute of the San Carlos Clinical Hospital (IdISSC), 28040 Madrid, Spain, University Institute of Industrial Pharmacy (IUFI), School of Pharmacy, Complutense University of Madrid, 28040 Madrid, Spain |
| authorships[9].author.id | https://openalex.org/A5015094639 |
| authorships[9].author.orcid | https://orcid.org/0000-0001-6258-2489 |
| authorships[9].author.display_name | Elena García‐Martín |
| authorships[9].countries | ES |
| authorships[9].affiliations[0].institution_ids | https://openalex.org/I4210114530 |
| authorships[9].affiliations[0].raw_affiliation_string | Department of Ophthalmology, Miguel Servet University Hospital, 50009 Zaragoza, Spain |
| authorships[9].affiliations[1].institution_ids | https://openalex.org/I255234318, https://openalex.org/I4210136512 |
| authorships[9].affiliations[1].raw_affiliation_string | Miguel Servet Ophthalmology Research Group (GIMSO), Aragon Health Research Institute (IIS Aragon), University of Zaragoza, 50009 Zaragoza, Spain |
| authorships[9].affiliations[2].institution_ids | https://openalex.org/I2801357902 |
| authorships[9].affiliations[2].raw_affiliation_string | National Ocular Researcha Network RD21/0002/0050, RICORS Red de Enfermedades Inflamatorias (RD21/0002), Carlos III Health Institute, 28220 Madrid, Spain |
| authorships[9].institutions[0].id | https://openalex.org/I4210114530 |
| authorships[9].institutions[0].ror | https://ror.org/01r13mt55 |
| authorships[9].institutions[0].type | healthcare |
| authorships[9].institutions[0].lineage | https://openalex.org/I4210114530 |
| authorships[9].institutions[0].country_code | ES |
| authorships[9].institutions[0].display_name | Hospital Universitario Miguel Servet |
| authorships[9].institutions[1].id | https://openalex.org/I4210136512 |
| authorships[9].institutions[1].ror | https://ror.org/03njn4610 |
| authorships[9].institutions[1].type | other |
| authorships[9].institutions[1].lineage | https://openalex.org/I4210136512 |
| authorships[9].institutions[1].country_code | ES |
| authorships[9].institutions[1].display_name | Instituto de Investigación Sanitaria Aragón |
| authorships[9].institutions[2].id | https://openalex.org/I2801357902 |
| authorships[9].institutions[2].ror | https://ror.org/00ca2c886 |
| authorships[9].institutions[2].type | nonprofit |
| authorships[9].institutions[2].lineage | https://openalex.org/I2801357902, https://openalex.org/I4387152914 |
| authorships[9].institutions[2].country_code | ES |
| authorships[9].institutions[2].display_name | Instituto de Salud Carlos III |
| authorships[9].institutions[3].id | https://openalex.org/I255234318 |
| authorships[9].institutions[3].ror | https://ror.org/012a91z28 |
| authorships[9].institutions[3].type | education |
| authorships[9].institutions[3].lineage | https://openalex.org/I255234318 |
| authorships[9].institutions[3].country_code | ES |
| authorships[9].institutions[3].display_name | Universidad de Zaragoza |
| authorships[9].author_position | middle |
| authorships[9].raw_author_name | Elena Garcia-Martin |
| authorships[9].is_corresponding | True |
| authorships[9].raw_affiliation_strings | Department of Ophthalmology, Miguel Servet University Hospital, 50009 Zaragoza, Spain, Miguel Servet Ophthalmology Research Group (GIMSO), Aragon Health Research Institute (IIS Aragon), University of Zaragoza, 50009 Zaragoza, Spain, National Ocular Researcha Network RD21/0002/0050, RICORS Red de Enfermedades Inflamatorias (RD21/0002), Carlos III Health Institute, 28220 Madrid, Spain |
| authorships[10].author.id | https://openalex.org/A5049602302 |
| authorships[10].author.orcid | https://orcid.org/0000-0003-0669-777X |
| authorships[10].author.display_name | Amaya Pérez del Palomar |
| authorships[10].countries | ES |
| authorships[10].affiliations[0].institution_ids | https://openalex.org/I255234318 |
| authorships[10].affiliations[0].raw_affiliation_string | Department of Mechanical Engineering, University of Zaragoza, 50018 Zaragoza, Spain |
| authorships[10].affiliations[1].institution_ids | https://openalex.org/I255234318 |
| authorships[10].affiliations[1].raw_affiliation_string | Biomaterials Group, Aragon Engineering Research Institute (I3A), University of Zaragoza, 50018 Zaragoza, Spain |
| authorships[10].institutions[0].id | https://openalex.org/I255234318 |
| authorships[10].institutions[0].ror | https://ror.org/012a91z28 |
| authorships[10].institutions[0].type | education |
| authorships[10].institutions[0].lineage | https://openalex.org/I255234318 |
| authorships[10].institutions[0].country_code | ES |
| authorships[10].institutions[0].display_name | Universidad de Zaragoza |
| authorships[10].author_position | last |
| authorships[10].raw_author_name | Amaya Pérez del Palomar |
| authorships[10].is_corresponding | False |
| authorships[10].raw_affiliation_strings | Biomaterials Group, Aragon Engineering Research Institute (I3A), University of Zaragoza, 50018 Zaragoza, Spain, Department of Mechanical Engineering, University of Zaragoza, 50018 Zaragoza, Spain |
| has_content.pdf | True |
| has_content.grobid_xml | True |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://www.mdpi.com/2227-9059/12/3/633/pdf?version=1710317982 |
| open_access.oa_status | gold |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Immune Analysis Using Vitreous Optical Coherence Tomography Imaging in Rats with Steroid-Induced Glaucoma |
| has_fulltext | True |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T10250 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 1.0 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2731 |
| primary_topic.subfield.display_name | Ophthalmology |
| primary_topic.display_name | Glaucoma and retinal disorders |
| related_works | https://openalex.org/W23766661, https://openalex.org/W2500847435, https://openalex.org/W1984678351, https://openalex.org/W74963343, https://openalex.org/W2109488902, https://openalex.org/W2239285033, https://openalex.org/W2056344052, https://openalex.org/W3118872369, https://openalex.org/W2975388422, https://openalex.org/W2075308789 |
| cited_by_count | 0 |
| locations_count | 5 |
| best_oa_location.id | doi:10.3390/biomedicines12030633 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S2737005842 |
| best_oa_location.source.issn | 2227-9059 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | True |
| best_oa_location.source.issn_l | 2227-9059 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | True |
| best_oa_location.source.display_name | Biomedicines |
| best_oa_location.source.host_organization | https://openalex.org/P4310310987 |
| best_oa_location.source.host_organization_name | Multidisciplinary Digital Publishing Institute |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310310987 |
| best_oa_location.license | cc-by |
| best_oa_location.pdf_url | https://www.mdpi.com/2227-9059/12/3/633/pdf?version=1710317982 |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | Biomedicines |
| best_oa_location.landing_page_url | https://doi.org/10.3390/biomedicines12030633 |
| primary_location.id | doi:10.3390/biomedicines12030633 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S2737005842 |
| primary_location.source.issn | 2227-9059 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | True |
| primary_location.source.issn_l | 2227-9059 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | True |
| primary_location.source.display_name | Biomedicines |
| primary_location.source.host_organization | https://openalex.org/P4310310987 |
| primary_location.source.host_organization_name | Multidisciplinary Digital Publishing Institute |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310310987 |
| primary_location.license | cc-by |
| primary_location.pdf_url | https://www.mdpi.com/2227-9059/12/3/633/pdf?version=1710317982 |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | https://openalex.org/licenses/cc-by |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Biomedicines |
| primary_location.landing_page_url | https://doi.org/10.3390/biomedicines12030633 |
| publication_date | 2024-03-13 |
| publication_year | 2024 |
| referenced_works | https://openalex.org/W2057266151, https://openalex.org/W2918874988, https://openalex.org/W3005666955, https://openalex.org/W4206485229, https://openalex.org/W1984475194, https://openalex.org/W1967450909, https://openalex.org/W2803214839, https://openalex.org/W2067267561, https://openalex.org/W2002319579, https://openalex.org/W2108824480, https://openalex.org/W2168582892, https://openalex.org/W1968012548, https://openalex.org/W2015900237, https://openalex.org/W2236375555, https://openalex.org/W2018143279, https://openalex.org/W2345532032, https://openalex.org/W2345660042, https://openalex.org/W3214736355, https://openalex.org/W3214161411, https://openalex.org/W2300528976, https://openalex.org/W1528523709, https://openalex.org/W3128404916, https://openalex.org/W1993097171, https://openalex.org/W2167122435, https://openalex.org/W3126876392, https://openalex.org/W1979742599, https://openalex.org/W2049915668, https://openalex.org/W2509227663, https://openalex.org/W2120891084, https://openalex.org/W2158232675, https://openalex.org/W1999419270, https://openalex.org/W2132924600, https://openalex.org/W3038112026, https://openalex.org/W2781945959, https://openalex.org/W4310638952, https://openalex.org/W3082783426, https://openalex.org/W4389087175, https://openalex.org/W2058722090, https://openalex.org/W204833777, https://openalex.org/W2795182622, https://openalex.org/W1526655781, https://openalex.org/W2006720649, https://openalex.org/W2159701614, https://openalex.org/W2017504740, https://openalex.org/W3036535050, https://openalex.org/W3013561740, https://openalex.org/W2106287544, https://openalex.org/W2281405694, https://openalex.org/W2333903415, https://openalex.org/W2969665967, https://openalex.org/W2948077003, https://openalex.org/W3006367551, https://openalex.org/W3008106741, https://openalex.org/W2792966011, https://openalex.org/W4210347726, https://openalex.org/W1976041506, https://openalex.org/W2946473464, https://openalex.org/W2327016921, https://openalex.org/W4290691624, https://openalex.org/W1803753774, https://openalex.org/W2099344639, https://openalex.org/W2058593952, https://openalex.org/W6608351303, https://openalex.org/W3010767137, https://openalex.org/W2265779583, https://openalex.org/W2137386887, https://openalex.org/W2608519953, https://openalex.org/W2963154222, https://openalex.org/W2914406467, https://openalex.org/W3036960582, https://openalex.org/W4288535238, https://openalex.org/W1847744871 |
| referenced_works_count | 72 |
| abstract_inverted_index.a | 2, 14, 92, 182, 201 |
| abstract_inverted_index.(p | 98 |
| abstract_inverted_index.an | 129 |
| abstract_inverted_index.as | 36 |
| abstract_inverted_index.be | 149, 200 |
| abstract_inverted_index.by | 44 |
| abstract_inverted_index.in | 17, 21, 33, 52, 54, 57, 104, 139, 177, 185, 194 |
| abstract_inverted_index.is | 1 |
| abstract_inverted_index.it | 24 |
| abstract_inverted_index.of | 95, 107, 191, 204 |
| abstract_inverted_index.to | 87, 148, 153 |
| abstract_inverted_index.(10 | 110 |
| abstract_inverted_index.OCT | 198 |
| abstract_inverted_index.SIG | 84, 126 |
| abstract_inverted_index.The | 9 |
| abstract_inverted_index.and | 39, 73, 78, 91, 120, 168, 181 |
| abstract_inverted_index.are | 41 |
| abstract_inverted_index.but | 20 |
| abstract_inverted_index.six | 82 |
| abstract_inverted_index.the | 6, 34, 50, 55, 105, 136, 150, 158, 170, 178, 189, 195 |
| abstract_inverted_index.two | 58 |
| abstract_inverted_index.< | 99 |
| abstract_inverted_index.Both | 125 |
| abstract_inverted_index.This | 47 |
| abstract_inverted_index.both | 76 |
| abstract_inverted_index.cell | 121 |
| abstract_inverted_index.drug | 66 |
| abstract_inverted_index.even | 176 |
| abstract_inverted_index.eye, | 180 |
| abstract_inverted_index.eyes | 85 |
| abstract_inverted_index.mean | 172 |
| abstract_inverted_index.most | 159 |
| abstract_inverted_index.noxa | 154 |
| abstract_inverted_index.over | 81 |
| abstract_inverted_index.peak | 164 |
| abstract_inverted_index.role | 16 |
| abstract_inverted_index.they | 156 |
| abstract_inverted_index.this | 140 |
| abstract_inverted_index.were | 157 |
| abstract_inverted_index.with | 65, 71, 101, 132, 163 |
| abstract_inverted_index.(SIG) | 61 |
| abstract_inverted_index.being | 135 |
| abstract_inverted_index.cells | 32, 109, 113, 117, 134 |
| abstract_inverted_index.could | 199 |
| abstract_inverted_index.first | 151 |
| abstract_inverted_index.major | 183 |
| abstract_inverted_index.plays | 13 |
| abstract_inverted_index.sexes | 77 |
| abstract_inverted_index.since | 155 |
| abstract_inverted_index.study | 48 |
| abstract_inverted_index.these | 40 |
| abstract_inverted_index.using | 197 |
| abstract_inverted_index.µm2) | 119 |
| abstract_inverted_index.0.05), | 100 |
| abstract_inverted_index.animal | 62 |
| abstract_inverted_index.cells) | 146 |
| abstract_inverted_index.change | 184 |
| abstract_inverted_index.higher | 93 |
| abstract_inverted_index.immune | 7, 11, 31 |
| abstract_inverted_index.loaded | 70 |
| abstract_inverted_index.models | 63, 127 |
| abstract_inverted_index.number | 94 |
| abstract_inverted_index.seemed | 147 |
| abstract_inverted_index.showed | 169 |
| abstract_inverted_index.study. | 141 |
| abstract_inverted_index.tended | 86 |
| abstract_inverted_index.useful | 202 |
| abstract_inverted_index.µm2), | 111, 115 |
| abstract_inverted_index.µm2). | 124 |
| abstract_inverted_index.Optical | 27 |
| abstract_inverted_index.changes | 51 |
| abstract_inverted_index.created | 64 |
| abstract_inverted_index.detects | 30 |
| abstract_inverted_index.dynamic | 102 |
| abstract_inverted_index.greater | 89 |
| abstract_inverted_index.healthy | 18, 79 |
| abstract_inverted_index.highest | 171 |
| abstract_inverted_index.largest | 137 |
| abstract_inverted_index.months. | 83 |
| abstract_inverted_index.present | 88 |
| abstract_inverted_index.rounded | 160 |
| abstract_inverted_index.smaller | 143 |
| abstract_inverted_index.system. | 8 |
| abstract_inverted_index.systems | 68 |
| abstract_inverted_index.(>250 | 123 |
| abstract_inverted_index.(10–50 | 114 |
| abstract_inverted_index.Glaucoma | 0 |
| abstract_inverted_index.However, | 142 |
| abstract_inverted_index.Studying | 188 |
| abstract_inverted_index.controls | 80 |
| abstract_inverted_index.delivery | 67 |
| abstract_inverted_index.features | 190 |
| abstract_inverted_index.glaucoma | 60 |
| abstract_inverted_index.immunity | 53 |
| abstract_inverted_index.isolated | 108 |
| abstract_inverted_index.monitors | 49 |
| abstract_inverted_index.pressure | 166 |
| abstract_inverted_index.produces | 25 |
| abstract_inverted_index.profile, | 131 |
| abstract_inverted_index.response | 12 |
| abstract_inverted_index.vitreous | 35, 56, 96, 196 |
| abstract_inverted_index.(50–250 | 118 |
| abstract_inverted_index.(isolated | 145 |
| abstract_inverted_index.Intensity | 173 |
| abstract_inverted_index.activated | 116 |
| abstract_inverted_index.analysis. | 46 |
| abstract_inverted_index.biomarker | 203 |
| abstract_inverted_index.coherence | 28 |
| abstract_inverted_index.comparing | 75 |
| abstract_inverted_index.complexes | 122 |
| abstract_inverted_index.glaucoma. | 205 |
| abstract_inverted_index.increase, | 167 |
| abstract_inverted_index.intensity | 90 |
| abstract_inverted_index.involving | 5 |
| abstract_inverted_index.opacities | 38, 97, 144, 193 |
| abstract_inverted_index.pathology | 4 |
| abstract_inverted_index.presented | 128 |
| abstract_inverted_index.responder | 152 |
| abstract_inverted_index.coinciding | 162 |
| abstract_inverted_index.percentage | 106 |
| abstract_inverted_index.population | 138 |
| abstract_inverted_index.tomography | 29 |
| abstract_inverted_index.(motility). | 187 |
| abstract_inverted_index.homeostatic | 15 |
| abstract_inverted_index.imbalances. | 26 |
| abstract_inverted_index.intraocular | 165 |
| abstract_inverted_index.machinery), | 175 |
| abstract_inverted_index.orientation | 186 |
| abstract_inverted_index.situations, | 19, 23 |
| abstract_inverted_index.subclinical | 10 |
| abstract_inverted_index.fluctuations | 103 |
| abstract_inverted_index.pathological | 22 |
| abstract_inverted_index.subsequently | 42 |
| abstract_inverted_index.(microspheres | 69 |
| abstract_inverted_index.characterised | 43 |
| abstract_inverted_index.computational | 45 |
| abstract_inverted_index.contralateral | 179 |
| abstract_inverted_index.dexamethasone | 72 |
| abstract_inverted_index.non-activated | 112, 133 |
| abstract_inverted_index.(intracellular | 174 |
| abstract_inverted_index.(recruitment), | 161 |
| abstract_inverted_index.multifactorial | 3 |
| abstract_inverted_index.hyperreflective | 37, 192 |
| abstract_inverted_index.steroid-induced | 59 |
| abstract_inverted_index.anti-inflammatory | 130 |
| abstract_inverted_index.dexamethasone/fibronectin), | 74 |
| cited_by_percentile_year | |
| corresponding_author_ids | https://openalex.org/A5015094639 |
| countries_distinct_count | 1 |
| institutions_distinct_count | 11 |
| corresponding_institution_ids | https://openalex.org/I255234318, https://openalex.org/I2801357902, https://openalex.org/I4210114530, https://openalex.org/I4210136512 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/3 |
| sustainable_development_goals[0].score | 0.8600000143051147 |
| sustainable_development_goals[0].display_name | Good health and well-being |
| citation_normalized_percentile.value | 0.07732353 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |